Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Blocking may align defects across skin layers and increase penetration

Delayed of may align skin-layer defects despite matched itch relief. A barrier benefit confined to that rescues from would instead support immune-driven cell loss.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 5 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Ageing mechanism

Main connectionExtracellular matrix and tissue mechanics

Direction

Lens

Puts the cause at the boundaries: the membranes, junctions and barriers that keep compartments apart.Interfaces and barriers

A double ring marks the main placement where a group contains several values.

Goal
Устойчивость к взаимному усилению бытовых нагрузок
Competing hypotheses
1
Published
2026-09-25
As a hypothesis
9 / 10Clarity of mechanism
6 / 10Few extra conditions
9 / 10Completeness of the answer
6 / 10Novelty of the idea
9 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
5 / 10Support from research
Poster: TRPV4 blockade increases tracer penetration
PosterOpen the sheet full size2026-09-26

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Signalling molecule

    Interleukin-6

    A secreted signalling molecule

    Where this hypothesis actsSkin exposed to wet friction, with itch reduction matched between interventions

    Hypotheses on this target 2
    Interleukin-6Lower level. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 11Neutralisation. Hypotheses on this target 11Supplementation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 0
    • Lower level
    • Synthesis suppression1
    • Neutralisation1
    • Supplementation
    • Accelerated excretion

    What is proposed

    Neutralisation

    Selectively suppress while preserving

    With whatNot stated in the record

    How that leaves -dependent intact; the blocking agent is not stated

    Possible result

    Possible preservation of and better prevention of repeated skin damage

    From the recordБлокада IL-31 сохраняет этот ремонтный процесс.

  2. Receptor or channel

    A protein involved in the formation and restoration of junctions between

    Where this hypothesis acts after wet friction, after the first protective response but before is complete

    Hypotheses on this target 1
    TRPV4Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Blockade. Hypotheses on this target 11Agonism. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function restoration. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Lower level
    • Higher level
    • Blockade1
    • Agonism
    • Desensitisation
    • Function restoration
    • Function preservation

    What is proposed

    Blockade

    Delay inhibition until after the first protective response

    With whatControlled genetic model

    HowDelayed before is complete, with keratinocyte-specific inactivation as a comparison

    Possible result

    Expected increase in vertically aligned barrier defects and compared with

    From the recordПредполагается, что отсроченная блокада TRPV4, начатая после первого защитного ответа, но до завершения восстановления соединений, увеличивает совпадение дефектов по глубине.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistPotassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTInterleukin-6. Hypotheses on this target 2Interleukin-6
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαTRPV4. Hypotheses on this target 1TRPV4
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin protection may depend on where damage occurs across its layers, as well as how much damage there is. The unexpected move is to propose that two treatments providing equal itch relief could leave different routes open through the skin because one interrupts repair beneath existing surface gaps. This is a hypothesis generated by the pipeline, not a measured treatment comparison.

The proposed mechanism, link by link
  1. Wet rubbing is proposed to create local gaps in the outer protective layer.
  2. -dependent repair is proposed to restore connections between living cells beneath those gaps, keeping a surface opening from becoming a route through both layers.
  3. after the first protective response but before repair finishes is proposed to change temporary gaps into gaps that remain open during the observation period.
  4. The resulting overlap between gaps in both layers is proposed to increase passage of an irritant.
  5. is proposed to preserve the deeper repair process, leaving fewer openings that coincide across layers.
  6. With itch relief and the early protective response held equal, fewer coinciding openings are predicted to reduce repeated injury.
A picture for it

Two overlapping sheets can each have holes yet still cover an opening if their holes sit in different places. Moving the holes into line creates a passage without increasing the number of holes.

Where the picture breaks: Skin repairs itself, and substances can spread sideways between layers. The proposal therefore has to establish whether aligned gaps are actually required for substantial passage of the chosen test substance during the chosen observation period.

  1. Master questionstep 01 of 04

    A therapy would restore the functional condition of middle-aged people's skin toward that of young people.

    Rests on: The stated goal is functional improvement toward a younger reference state.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Skin would resist everyday stresses that amplify one another's damaging effects.

    Rests on: Resistance to interacting everyday stresses is treated as one component of younger skin function.

    Assumption

    The goal does not establish that this resistance differs between middle-aged and young skin, or define how restoring it would be measured.

  3. Gap questionstep 03 of 04

    With equal itch relief, blocking interleukin-31 (IL-31), an immune signalling protein associated with itch, might preserve the protective response to wet rubbing and prevent repeated injury differently from delayed suppression of transient receptor potential (TRP) channels, a family of channels that carry charged particles across cell membranes.

    Rests on: The previous stage identifies interacting everyday stresses as a target, but supplies no route from that target to this particular treatment comparison.

    Leap

    The supplied material does not establish why these interventions, their timing, or wet rubbing specifically resolve the preceding goal. Evidence about itch treatment alone does not supply the missing connection to protective responses and repeated injury.

  4. Hypothesisstep 04 of 04

    Damage in the , the outer protective layer of dead skin cells, is proposed to become more permeable when it lines up with gaps between cells in the , the living portion of the skin's outer covering. Delayed is proposed to interrupt repair of those cell connections, whereas is proposed to preserve it, producing different levels of repeated injury despite equal itch relief and equal early protection.S1S4

    Rests on: The preceding comparison supplies the need for a mechanism separating the treatments. S1, in Skin Pharmacology and Physiology in 2013, reports that activation strengthened the barrier associated with , seals between neighbouring cells, in cultured human , the main cells of the ; its screened abstract does not establish repair after wet rubbing or the effects of delayed . S4, in Communicative & Integrative Biology in 2010, describes involvement in developing cell connections, but does not establish alignment of damage across layers or the comparison with .

    Supported by literature

What is carried, and what is not. Screened sources speak to two of the six mechanism links at a broader level: mechanical stress affecting the skin barrier and involvement in cell connections; S6, in Acta Dermato-Venereologica in 2006, connects mechanical stress with water in healthy volunteers but does not establish wet-rubbing damage or aligned gaps. None of the supplied sources establishes the sequence from delayed through interrupted repair and aligned defects to greater penetration and repeated injury.S6

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The goal does not establish that this resistance differs between middle-aged and young skin, or define how restoring it would be measured.
  • Gap question. The supplied material does not establish why these interventions, their timing, or wet rubbing specifically resolve the preceding goal. Evidence about itch treatment alone does not supply the missing connection to protective responses and repeated injury. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Greater passage of a , a detectable substance used to track penetration, could be attributed to alignment even if treatment simply creates more damage in one layer. Sideways movement could also make entry appear to require vertically aligned gaps when it does not. What closes it: The proposed layer-by-layer maps must compare the damaged fraction of each layer alongside the frequency of overlapping defects and passage. The region, observation period and rule for identifying overlap must be fixed in advance, and sideways spread must be measured separately.
  • A treatment difference could be credited to repair timing when the treatments actually produce different itch relief or different early protective responses. Conversely, a negative result could reflect beginning after repair was already complete. What closes it: Equal itch relief and equal early protection require verification wherever those responses are represented. The design must confirm that is inhibited during unfinished repair and separately assess begun after confirmed repair; the supplied material gives no timing schedule or criteria for these conditions.
  • A result in a model without could be read as excluding their contribution in intact skin, while a net benefit in their presence could conceal simultaneous harm to cell connections. The rival predicts that prevents from engulfing still-recoverable skin cells. What closes it: Separating the routes requires comparisons with and without , the proposed shutdown restricted to , and measurements of both cell connections and of recoverable cells. The rival additionally requires confirmation that can physically reach the affected skin cells.

What would make this wrong. The central chain would be contradicted if, without and with confirmed inhibition during unfinished repair, delayed did not impair cell connections, increase aligned gaps or increase passage relative to . Its alignment-dependent explanation would also fail for the tested substance and observation period if penetration did not depend on overlap when the damaged fraction of each layer was comparable. Improvement confined to models containing , accompanied by prevention of of recoverable cells, would instead support the supplied rival.

What it would change. If the mechanism held, work toward restoring younger skin function would have to consider the spatial arrangement and repair timing of damage, alongside itch relief and the amount of damage. A treatment could reduce symptoms while leaving a more continuous route through the skin's protective layers. Even then, the supplied work would not establish an age-dependent difference, restoration to a young reference state, or lasting benefit in middle-aged people; its proposed stability outcome is not operationally defined.

Sources read · 10

3 literature searches, 6 full texts, 4 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers itAbstract only

Activation of TRPV4 strengthens the tight-junction barrier in human epidermal keratinocytes. · Skin pharmacology and physiology · 2013

“In conclusion, we demonstrated that the activation of TRPV4 strengthened the TJ-associated barrier of epidermal cells.”

Does not settle: Источник показывает усиление барьера плотных контактов при активации TRPV4 в культуре человеческих кератиноцитов. Он не устанавливает последствия блокады TRPV4 после влажного трения, пространственное совпадение дефектов между слоями кожи, проникновение раздражителя, роль IL-31, зуд или стабильность SPV_1.

S2Partly answers itAbstract only

TRPV4 Regulates Tight Junctions and Affects Differentiation in a Cell Culture Model of the Corneal Epithelium. · Journal of cellular physiology · 2017

“We showed that TRPV4 activity was necessary to establish the TJ.”

Does not settle: Источник описывает модель эпителия роговицы in vitro. Он не устанавливает последствия влажного трения в коже, пространственное совпадение дефектов по слоям эпидермиса, время блокады TRPV4, проникновение раздражителя, роль IL-31, зуд или SPV_1.

S3Background

Bioactive Polysaccharides from Fermented Dendrobium officinale: Structural Insights and Their Role in Skin Barrier Repair. · Molecules (Basel, Switzerland) · 2025

“recovered levels of filaggrin (FLG), aquaporin 3 (AQP3), transient receptor potential vanilloid 4 (TRPV4), cathelicidin antimicrobial peptide (CAMP)/LL-37, and adiponectin (ADIPOQ);”

Does not settle: Источник не исследует влажное трение, межклеточные соединения, пространственное совпадение дефектов по глубине, проникновение раздражителя, блокаду TRPV4 или IL-31, зуд, повторное повреждение либо SPV_1.

S4Partly answers it

The TRPV4 cation channel: A molecule linking skin temperature and barrier function. · Communicative & integrative biology · 2010

“TRPV4 associates with the E-cadherin complex via β-catenin, and thereby participates in the promotion of cell-cell junction development.”

Does not settle: Источник не исследует влажное трение, пространственное совпадение дефектов по глубине, проникновение раздражителя, отсроченную блокаду TRPV4, IL-31, зуд, повторное повреждение или SPV_1.

S5Background

Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. · The Journal of allergy and clinical immunology · 2012

“increased desquamation under mechanical stress was demonstrated. Loss of keratin patterns, which are critical for corneocyte stabilization, is likely attributable to fragility in the Flg(-/-) SC. Antigens penetrated the Flg(-/-) SC more efficiently”

Does not settle: Источник описывает мышей с полным дефицитом филаггрина. Он не устанавливает эффект влажного трения, локальное совпадение дефектов по глубине, восстановление межклеточных соединений, роль TRPV4 или IL-31, время блокады, зуд, повторное повреждение и SPV_1.

S6Partly answers it

Mechanical properties and barrier function of healthy human skin. · Acta dermato-venereologica · 2006

“Water permeability of the epidermis was significantly affected by the application of mechanical stress to the skin and vice versa, the mechanical properties of the skin were altered when compromising the barrier.”

Does not settle: Источник показывает связь механического воздействия с проницаемостью эпидермиса у здоровых добровольцев. В тексте остаются открытыми влажное трение, локальные дефекты рогового слоя, межклеточные соединения живого эпидермиса, TRPV4, IL-31, сроки вмешательства, проникновение раздражителя и SPV_1.

S7BackgroundAbstract only

Photomechanical transcutaneous delivery of macromolecules. · The Journal of investigative dermatology · 1998

“A mechanical (stress) pulse generated by a single laser pulse was shown to transiently increase the permeability of the stratum corneum in vivo.”

Does not settle: This abstract does not establish effects of wet friction, TRPV4 or IL-31 blockade, junction repair in viable epidermis, spatial alignment of defects, itch, repeated damage, or SPV_1.

S8Background

Assessment of non-invasive techniques and herbal-based products on dermatological physiology and intercellular lipid properties. · Heliyon · 2020

“Transepidermal water loss (TEWL) was measured regularly in order to provide further information on the epidermal permeability barrier—either normal, experimentally perturbed, or in diseased conditions [ ].”

Does not settle: Источник не исследует влажное трение, TRPV4, IL-31, межклеточные соединения живого эпидермиса, пространственное совпадение дефектов, проникновение раздражителя или SPV_1.

S9BackgroundAbstract only

Interleukin-31: The "itchy" cytokine in inflammation and therapy. · Allergy · 2021

“In AD, IL-31 has been identified as one of the main "drivers" of its cardinal symptom, pruritus.”

Does not settle: Источник оставляет открытыми роль TRPV4, восстановление межклеточных соединений, пространственное совпадение дефектов по слоям кожи, проницаемость раздражителей, сроки блокады и сравнительную эффективность блокады IL-31.

S10Background

IL-31/33 Axis in Atopic Dermatitis. · International journal of molecular sciences · 2025

“Anti-IL-31 receptor α (IL-31RA) agents (e.g., nemolizumab) demonstrate significant reductions in pruritus and disease severity across clinical trials.”

Does not settle: Источник не устанавливает влияние блокады IL-31 на восстановление межклеточных соединений, TRPV4-зависимый ремонт, пространственное совпадение дефектов, проникновение раздражителя, повторное повреждение или SPV_1.

The gap this hypothesis explains

Do targeted versus delayed blockers equally relieve itching yet differ in wet-rubbing protection and repeated skin damage?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

При одинаковом уменьшении зуда позволяют ли избирательное подавление и отсроченное подавление по-разному сохранить защитную реакцию на влажное трение и прекратить повторное повреждение кожи?

What this question is asking

The question concerns whether two ways of reducing itching also differ in preserving the skin’s response to potentially damaging rubbing when wet. It compares selectively suppressing interleukin-31 (IL-31), a chemical messenger involved in itching, with suppressing transient receptor potential (TRP) channel signals after a delay. With itch relief held equal, the outcomes are preservation of a protective response to wet rubbing and whether repeated skin damage stops. Equal itch relief is a condition of the comparison, not an established finding, and the question does not specify the channels, the delay, or what counts as a protective response. Its stated motivation concerns middle-aged skin, whereas the supplied evidence mainly concerns atopic dermatitis, an inflammatory skin condition.

What the terms mean
Interleukin-31 (IL-31)
A chemical messenger involved in communication between cells and implicated in itching in the supplied sources. Suppressing it is the targeted intervention in the question [S2, S3].
Selective suppression or targeted blocking
Reducing the activity of a specified target, here interleukin-31. The wording identifies the intended target; it does not establish that all other skin or sensory functions remain unaffected.
Transient receptor potential (TRP) channels
A family of proteins that allow electrically charged particles to cross cell membranes and participate in cellular signals. This names a family rather than one interchangeable target; the question does not specify which members would be suppressed.
Transient receptor potential vanilloid (TRPV) channels
A subgroup of the transient receptor potential channel family. The supplied temperature-related source discusses possible effects of blocking this subgroup [S5].
Transient receptor potential vanilloid 1 (TRPV1)
A particular channel associated with transmission of both pain and itch signals. Its involvement in both sensations is relevant to whether itch relief could accompany changes in other sensory responses, but does not establish an effect on wet-rubbing protection [S7].
Transient receptor potential vanilloid 3 (TRPV3)
A particular channel whose activation in skin cells can lead to release of substances involved in itching and other skin functions. The supplied sources connect it both to inflammatory signaling and to functions including barrier formation and wound healing [S6, S8].
Delayed suppression
Starting to reduce a signal after some interval. The question provides neither the interval nor the event that starts it, so this does not identify a defined treatment schedule.
Atopic dermatitis
An inflammatory skin condition associated here with itching and impaired skin protection. It is the setting of most supplied findings, which do not establish equivalent effects in middle-aged skin generally.
Sensory nerves and increased sensitivity
Sensory nerves carry information about bodily stimuli. Increased sensitivity means stimuli can more readily provoke a response such as itching; the supplied sources associate this with scratching and worsening skin problems [S1, S4].
Central nervous system
The brain and spinal cord. The supplied source describes pain and itch signals reaching this system through sensory nerve cells [S7].
Keratinocytes
Cells of the skin’s outer layer. In the supplied sources, activation of one channel type in these cells causes release of substances that influence itching and other skin functions [S6, S8].
Inflammation and inflammatory messengers
Inflammation is a tissue response involving cellular activity and chemical signals; inflammatory messengers help initiate or regulate it. The supplied sources connect these processes to itching and worsening skin-barrier function [S4, S6].
Skin barrier
The protective function of the skin’s outer layers. Barrier impairment means this protection is weakened; the sources discuss it separately from the amount of itching [S4, S5].
Wet rubbing and protective response
Wet rubbing means friction involving wet skin or a wet contacting surface. A protective response would be a response that helps limit resulting harm, but the question does not specify what response would be measured.
Repeated skin damage
Skin injury that recurs rather than remaining a single event. The question asks whether this recurrence stops, which is a different outcome from reduced itching.
Corns and calluses
Localized areas of thickened skin discussed in the supplied source as consequences of pressure and friction. That finding does not address the proposed itch-treatment comparison [S9].
What turns on the answer
  • Selective messenger suppression performs better At equal itch relief, selectively suppressing the messenger would preserve more of the response that limits harmful wet rubbing and reduce repeated damage more effectively. Under the question’s proposed mechanism, continued protection would distinguish this approach even when itching improves equally.
  • Delayed channel suppression performs better At equal itch relief, delaying channel suppression would preserve more protection against wet rubbing and reduce repeated damage more effectively. Under the question’s proposed mechanism, the timing of suppression would matter for protection beyond its effect on itching.
  • Neither approach performs better Equal itch relief would be accompanied by equivalent protection and repeated-damage outcomes. That could mean both preserve protection and stop injury, or that both leave injury unresolved; equivalence alone would not establish success.
  • Protection and damage outcomes diverge One approach could preserve the measured protective response better without stopping repeated damage more effectively. That outcome would mean the protective-response measurement alone does not determine whether the skin continues to be injured.
Why it matters

The sources describe a sequence in which increased sensitivity to itch leads to scratching, which worsens inflammation and weakens the skin’s protective barrier [S4]. Reducing itch could interrupt that sequence, but itch relief alone does not establish that repeated injury has stopped. The channel family under discussion also includes members involved in pain signals and several skin functions, so the question concerns more than the amount of itching [S7, S8]. If protection against damaging rubbing differs between treatments, judging them solely by itch relief could miss that difference; the supplied sources do not establish whether it occurs.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Различие вмешательств определяется пространственным совпадением повреждений и . После влажного трения верхний слой получает локальные дефекты. -зависимое под этими дефектами ограничивает образование сквозных путей проникновения раздражителя. Предполагается, что отсроченная , начатая после первого защитного ответа, но до завершения , увеличивает совпадение дефектов по глубине. сохраняет этот ремонтный процесс. Поэтому при одинаковом уменьшении зуда и одинаковой ранней защитной реакции подавление лучше предотвращает повторное повреждение. Сохранение пространственной разобщённости дефектов стабилизирует SPV_1.

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

и проектирование : модель двух защитных элементов и . Значение рассмотрено в [материале Dominate and Defeat ](https://ntrs.nasa.gov/citations/20240013667). Для данного исследования используется точное разложение через : = × + × [(1 − )(1 − )]. A означает дефект в заданном участке и временном окне; B означает дефект соединений под тем же участком; и являются вероятностями этих событий; является их ; является вероятностью их совместного возникновения. модели: для выбранного и короткого окна наблюдения выраженное проникновение требует совпадения обоих дефектов. Это допущение проверяют отдельно, включая боковое распространение . Формула не является готовой моделью всей . Предлагаемая состоит в том, что подавление превращает общий эпизод трения в двух слоёв.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

В модели без отсроченная увеличит частоту совпадающих по глубине дефектов и по сравнению с . Эффект воспроизведёт выключение только в . При сопоставимой доле дефектов каждого слоя различие будет зависеть от их . Перенос начала на момент после подтверждённого уменьшит эффект. Если же улучшит барьер исключительно при наличии и спасёт поглощаемые , результат поддержит IH_Q_L3_M_G2_2_01.

Would tell it apart from at least one rival. The prediction specifies observable comparative changes in defects and tracer penetration, replication through cell-specific TRPV4 inactivation, and dependence on spatial correlation and blockade timing. No rival prediction was supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

позволяет совместить карты дефектов , и . Биологическое основание: активация поддерживала формирование человеческих . [Kida et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22374181/). Возрастную зависимость, и результат отсроченной необходимо установить экспериментально.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

В модели без отсроченная увеличит частоту совпадающих по глубине дефектов и по сравнению с . Эффект воспроизведёт выключение только в . При сопоставимой доле дефектов каждого слоя различие будет зависеть от их . Перенос начала на момент после подтверждённого уменьшит эффект. Если же улучшит барьер исключительно при наличии и спасёт поглощаемые , результат поддержит may prolong skin damage by engulfing that could recover.

  • Rival 01 of 01
    Macrophages may prolong skin damage by engulfing keratinocytes that could recover

    Not yet published.

    What would separate them

    Macrophages may prolong skin damage by engulfing keratinocytes that could recover predicts: В модели кожи с и отсроченное подавление уменьшит вторичную потерю сильнее при сопоставимом подавлении ответа на и одинаковой . Макрофагоспецифическое выключение воспроизведёт преимущество, а удаление устранит его. Решающий результат: клетки, которые в поглощаются, после предотвращения сохраняют , возвращают нормальную и участвуют в восстановлении . Отсутствия перед для такого вывода недостаточно. Если преимущество сохраняется без и определяется пространственным совпадением дефектов слоёв, результат поддержит this hypothesis.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

0 of 1 cited studies could be located, and 0 of 0 figures are not carried by one that resolved.

CitationsNo citation resolvedFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

1 citation handle extracted; 3 Europe PMC searches run; 52 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.